We conducted a joint presentation with Tokyo University of Pharmacy and Life Sciences at the 144th Annual Meeting of the Pharmaceutical Society of Japan, discussing the usefulness of King Agaricus KA21.
We verified the effects of King Agaricus KA21 intake on the gut bacteria of mice. As a result, we confirmed an increase in Akkermansia muciniphila, a type of gut bacteria abundant in the intestines of long-lived individuals and expected to have anti-obesity effects.
Presentation ID: 29P-am311